✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Jafron Biomedical Co Ltd

Common Name
Jafron Biomedical
Country
China (Mainland)
Sector
Healthcare
Industry
Medical Devices
Employees
2,200
Ticker
300529
Exchange
Shenzhen Stock Exchange
Description
Jafron Biomedical Co. Ltd. is a notable entity in the field of biotechnology, primarily focused on the research, development, and production of advanced medical devices, particularly in the area of bl...

Jafron Biomedical's GHG Emissions Data Preview

In 2025, Jafron Biomedical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Jafron Biomedical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)20252024
Total Scope 1
5,595.53a
8,644.93a
Total Scope 2
Unspecified Calculation Method
8,378.58a
10,664.54a
Total Scope 3
N/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
19.4716a
23.5652a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=300529&reporting_period=2025"

Verified Sources Behind Jafron Biomedical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Jafron Biomedical's ESG Report 2025
a. Jafron Biomedical's ESG Report 2025

Insights into Jafron Biomedical's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Jafron Biomedical amounted to 13,974.11 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Jafron Biomedical decreased by 27.63%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Jafron Biomedical's Scope 1 Emissions Over Time

2024202502.5 k5 k7.5 k10 ktCO2e-35%
  • Total Scope 1
  • Year-over-Year Change

What are Jafron Biomedical's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Jafron Biomedical were 5,595.53 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2024), Jafron Biomedical's Scope 1 emissions decreased by 35.27%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Jafron Biomedical's Scope 2 emissions?

In 2025, Jafron Biomedical reported Scope 2 greenhouse gas (GHG) emissions of 8,378.58 tCO₂e without specifying the calculation method.a

Has Jafron Biomedical reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Jafron Biomedical's Scope 2 emissions (Unspecified Calculation Method) fell by 21.44% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does Jafron Biomedical use for Scope 2 reporting?

In 2025, Jafron Biomedical reported its Scope 2 emissions using an unspecified methodology.a

Jafron Biomedical's Scope 2 Emissions Over Time

2024202503 k6 k9 k12 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Jafron Biomedical’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Jafron Biomedical reported Scope 1 greenhouse gas (GHG) emissions of 5,595.53 tCO₂e and total revenues of USD 287 millions. This translates into an emissions intensity of 19.47 tCO₂e per millions USD.a

Jafron Biomedical's Scope 1 Emissions Intensity Compared to Peers

101001,00010,000100,000Scope 1 Emissions (tCO2e)10502002,00010,000Revenues (Millions of USD)Draegerwerk AG & CoYear: 2025Scope 1: 30,584 tCO2eRevenue: $M 4,094Scope 1 Intensity: 7.47 tCO2e/$MNihon KohdenYear: 2025Scope 1: 3,893 tCO2eRevenue: $M 1,503Scope 1 Intensity: 2.59 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MNolatoYear: 2025Scope 1: 1,685 tCO2eRevenue: $M 1,029Scope 1 Intensity: 1.64 tCO2e/$MEmbla MedicalYear: 2025Scope 1: 2,290 tCO2eRevenue: $M 5,872Scope 1 Intensity: 0.39 tCO2e/$MElektaYear: 2026Scope 1: 4,530 tCO2eRevenue: $M 1,802Scope 1 Intensity: 2.51 tCO2e/$MGN Store NordYear: 2025Scope 1: 2,912 tCO2eRevenue: $M 2,642Scope 1 Intensity: 1.10 tCO2e/$MMicroport ScientificYear: 2023Scope 1: 3,168 tCO2eRevenue: $M 951Scope 1 Intensity: 3.33 tCO2e/$MBICO GroupYear: 2024Scope 1: 37 tCO2eRevenue: $M 157Scope 1 Intensity: 0.24 tCO2e/$MStratecYear: 2024Scope 1: 814 tCO2eRevenue: $M 268Scope 1 Intensity: 3.04 tCO2e/$MSectraYear: 2026Scope 1: 130 tCO2eRevenue: $M 382Scope 1 Intensity: 0.34 tCO2e/$MMedartis HoldingYear: 2025Scope 1: 1,062 tCO2eRevenue: $M 340Scope 1 Intensity: 3.13 tCO2e/$MEckert & ZieglerYear: 2025Scope 1: 1,656 tCO2eRevenue: $M 367Scope 1 Intensity: 4.52 tCO2e/$MVitrolifeYear: 2025Scope 1: 610 tCO2eRevenue: $M 374Scope 1 Intensity: 1.63 tCO2e/$MClassysYear: 2024Scope 1: 283 tCO2eRevenue: $M 166Scope 1 Intensity: 1.71 tCO2e/$MVenus Medtech (Hangzhou)Year: 2024Scope 1: 31 tCO2eRevenue: $M 65Scope 1 Intensity: 0.49 tCO2e/$MMicroport Cardioflow MedtechYear: 2023Scope 1: 268 tCO2eRevenue: $M 47Scope 1 Intensity: 5.65 tCO2e/$MMicroPort MedBotYear: 2023Scope 1: 68 tCO2eRevenue: $M 15Scope 1 Intensity: 4.59 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MYuwellYear: 2023Scope 1: 2,201 tCO2eRevenue: $M 1,122Scope 1 Intensity: 1.96 tCO2e/$MSnibeYear: 2025Scope 1: 2,590 tCO2eRevenue: $M 654Scope 1 Intensity: 3.96 tCO2e/$MUnited ImagingYear: 2024Scope 1: 3,123 tCO2eRevenue: $M 1,411Scope 1 Intensity: 2.21 tCO2e/$MMindrayYear: 2025Scope 1: 7,116 tCO2eRevenue: $M 4,754Scope 1 Intensity: 1.50 tCO2e/$MLifeTech ScientificYear: 2023Scope 1: 1,528 tCO2eRevenue: $M 178Scope 1 Intensity: 8.57 tCO2e/$MJafron BiomedicalYear: 2025Scope 1: 5,596 tCO2eRevenue: $M 287Scope 1 Intensity: 19.47 tCO2e/$M

How does Jafron Biomedical's GHG emissions intensity compare to its peers?

In 2025, Jafron Biomedical reported a Scope 1 emissions intensity of 19.47 tCO₂e per millions USD. Compared to the peer group median of 2.09, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Jafron Biomedical rank on GHG emissions intensity within its industry?

In 2025, Jafron Biomedical ranked 25 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Jafron Biomedical among the least efficient performers, with one of the highest emissions intensities in its sector.a

Want Full Access to Jafron Biomedical's GHG Emissions Dataset?
Start 30-Day Free Trial